Connection

Robert Haile to Risk Assessment

Back to Details
This is a "connection" page, showing publications Robert Haile has written about Risk Assessment.
Robert Haile
Connection Strength
0.636
Risk Assessment
  1. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):1021-30.
    View in: PubMed
    Score: 0.049
  2. Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2829-39.
    View in: PubMed
    Score: 0.041
  3. Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer. JAMA Netw Open. 2019 09 04; 2(9):e1912259.
    View in: PubMed
    Score: 0.027
  4. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020 01; 22(1):15-25.
    View in: PubMed
    Score: 0.026
  5. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. Int J Cancer. 2020 01 15; 146(2):363-372.
    View in: PubMed
    Score: 0.026
  6. Continued Increase in Melanoma Incidence across all Socioeconomic Status Groups in California, 1998-2012. J Invest Dermatol. 2017 11; 137(11):2282-2290.
    View in: PubMed
    Score: 0.023
  7. Determining the familial risk distribution of colorectal cancer: a data mining approach. Fam Cancer. 2016 Apr; 15(2):241-51.
    View in: PubMed
    Score: 0.021
  8. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol. 2015 May; 1(2):214-21.
    View in: PubMed
    Score: 0.020
  9. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut. 2015 Jan; 64(1):101-10.
    View in: PubMed
    Score: 0.018
  10. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014 May; 146(5):1208-11.e1-5.
    View in: PubMed
    Score: 0.018
  11. Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1547-56.
    View in: PubMed
    Score: 0.017
  12. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Eur J Cancer. 2013 May; 49(7):1578-87.
    View in: PubMed
    Score: 0.017
  13. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol. 2013 Feb 01; 31(4):433-9.
    View in: PubMed
    Score: 0.017
  14. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 2013 Apr; 144(4):799-807.e24.
    View in: PubMed
    Score: 0.017
  15. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst. 2012 Sep 19; 104(18):1363-72.
    View in: PubMed
    Score: 0.016
  16. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2012 Nov 15; 84(4):917-24.
    View in: PubMed
    Score: 0.016
  17. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut. 2012 Sep; 61(9):1299-305.
    View in: PubMed
    Score: 0.015
  18. Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Res Treat. 2012 Jan; 131(2):571-80.
    View in: PubMed
    Score: 0.015
  19. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer. 2011 Nov 01; 129(9):2256-62.
    View in: PubMed
    Score: 0.015
  20. Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol. 2011 Apr; 117(4):899-905.
    View in: PubMed
    Score: 0.015
  21. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010 Jul 21; 102(14):1012-22.
    View in: PubMed
    Score: 0.014
  22. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 May 10; 28(14):2404-10.
    View in: PubMed
    Score: 0.014
  23. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst. 2010 Apr 07; 102(7):475-83.
    View in: PubMed
    Score: 0.014
  24. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst. 2010 Mar 17; 102(6):391-400.
    View in: PubMed
    Score: 0.014
  25. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010 Feb 15; 16(4):1331-9.
    View in: PubMed
    Score: 0.014
  26. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2):491-8.
    View in: PubMed
    Score: 0.014
  27. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010 Feb 03; 102(3):193-201.
    View in: PubMed
    Score: 0.014
  28. The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):967-75.
    View in: PubMed
    Score: 0.013
  29. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst. 2009 Feb 18; 101(4):267-76.
    View in: PubMed
    Score: 0.013
  30. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group. J Clin Oncol. 2008 Mar 20; 26(9):1411-8.
    View in: PubMed
    Score: 0.012
  31. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study. J Natl Cancer Inst. 2008 Jan 02; 100(1):32-40.
    View in: PubMed
    Score: 0.012
  32. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst. 2007 Jan 17; 99(2):129-36.
    View in: PubMed
    Score: 0.011
  33. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. J Natl Cancer Inst. 2006 Oct 18; 98(20):1494-500.
    View in: PubMed
    Score: 0.011
  34. Fat, fiber, meat and the risk of colorectal adenomas. Am J Gastroenterol. 2005 Dec; 100(12):2789-95.
    View in: PubMed
    Score: 0.010
  35. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005 Apr 27; 293(16):1979-85.
    View in: PubMed
    Score: 0.010
  36. Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst. 2004 Jun 16; 96(12):921-5.
    View in: PubMed
    Score: 0.009
  37. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003 Dec 03; 95(23):1765-71.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.